|
The BioMedical Admissions Test (also known as BMAT) is an aptitude test used as part of the admissions process for Medicine, Veterinary Medicine or Biomedical Sciences in some universities in the United Kingdom, Singapore and the Netherlands. It is the successor of the Medical and Veterinary Sciences Admissions Test (MVAT). ==History== BMAT was developed by the Admissions Testing Service in response to requests from academics at medical and veterinary schools for an assessment that would enable them to differentiate between applicants who appear equally well qualified and suited to the course, and provide a way of assessing the potential of students who have a range of different qualifications.〔() http://www.admissionstestingservice.org/our-services/medicine-and-healthcare/bmat/why-use-bmat/ Retrieved 10 January 2014〕 Initially, it was taken up by Oxford University for Medicine and Physiology (replacing the OMAT); the University of Cambridge for Medicine and Veterinary Science (replacing the MVAT); University College London, for Medicine; and the Royal Veterinary College for Veterinary Science. From 2011, the new Lee Kong Chian School of Medicine (LKC Medicine) in Singapore, a partnership between Imperial College London and Nanyang University, started using BMAT as part of its entry process for Medicine. The most recent universities to introduce BMAT as part of their entry requirements for Medicine courses are Brighton and Sussex Medical School (BSMS) (for 2013–14 entry and later), Leiden University in the Netherlands (for 2014 entry and later), the University of Leeds (for 2015 entry and later) and Lancaster University (for 2016 entry and later). 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「BioMedical Admissions Test」の詳細全文を読む スポンサード リンク
|